Interaction of pregnancy and autoimmune rheumatic disease

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Østensen, Monika ^a   Villiger, Peter M ^a   Förger, Frauke ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Ankylosing spondylitis; Disease onset; Immune response; Pregnancy; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; COLLAGEN; ESTRADIOL; GAMMA INTERFERON; GESTAGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR4 ANTIGEN; HLA DRB1 ANTIGEN; HORMONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; PLACENTA PROTEIN 14; PROGESTERONE; RHEUMATOID FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CIRCULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FETUS CELL; HELPER CELL; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; MATERNAL BLOOD; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PSORIATIC ARTHRITIS; PUERPERIUM; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHIMERISM; CYTOKINES; FEMALE; FETUS; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; SPONDYLITIS, ANKYLOSING;

EID: 84858451461     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.013     Document Type: Review

References (133)

1. Medawar Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953, 44:320-338.
2. Munoz-Suano A., Hamilton A.B., Betz A.G. Gimme shelter: the immune system during pregnancy. Immunol Rev May 2011, 241(1):20-38.
3. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996, 93:705-708.
4. Burns D.N., Nourjah P., Wright D.J., Minkoff H., Landesman S., Rubinstein A., et al. Changes in immune activation markers during pregnancy and postpartum. J Reprod Immunol 1999, 42(2):147-165.
5. Adams Waldorf K.M., Nelson J.L. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest 2008, 37(5):631-644.
6. Wallenius M., Skomsvoll J.F., Irgens L.M., Salvesen K.A., Koldingsnes W., Mikkelsen K., et al. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis Feb 2010, 69(2):332-336.
7. Davidson L. The Scientific Advisory Committee of the Empire Rheumatism Council. A controlled investigation into the aetiology and clinical features of rheumatoid arthritis. BMJ 1950, 8:799-809.
8. Oka M. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis 1953, 12(3):227-229.
9. Iijima T., Tada H., Hidaka Y., Yagoro A., Mitsuda N., Kanzaki T., et al. Prediction of postpartum onset of rheumatoid arthritis. Ann Rheum Dis 1998, 57(8):460-463.
10. Silman A., Kay A., Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992, 35:152-155.
11. Lansink M., de Boer A., Dijkmans B., et al. The onset of rheumatoid arthritis in relation to pregnancy and childbirth. Clin Exp Rheumatol 1993, 11:171-174.
12. Nelson J.L., Østensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997, 23:195-212.
13. Hazes J.M.W., Dijkmans B.A.C., Vandenbroucke J.P., et al. Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum 1990, 33:1770-1775.
14. Spector T.D., Roman E., Silman A.J. The pill, parity, and rheumatoid arthritis. Arthritis Rheum 1990, 33:782-789.
15. Dugowson C.E., Nelson J.L., Koepsell T.D., et al. Nulliparity as a risk factor for rheumatoid arthritis. Arthritis Rheum 1991, 34:S48. (abstract).
16. Brennan P., Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994, 37:808-813.
17. Winchester R., Dwyer E., Rose S. The genetic basis of rheumatoid arthritis. The shared epitope hypothesis. Rheum Dis Clin North Am 1992, 18:761-783.
18. Rak J.M., Maestroni L., Balandraud N., Guis S., Boudinet H., Guzian M.C., et al. Transfer of shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009, 60:73-80.
19. Yan Z., Aydelotte T., Gadi V.K., Guthrie K.A., Nelson J.L., et al. Acquisition of the rheumatoid arthritis shared epitope through microchimerism. Arthritis Rheum 2011, 63:640-644.
20. Guthrie K.A., Dugowson C.E., Voigt L.F., Koepsell T.D., Nelson J.L. Does pregnancy provide vaccine-like protection against rheumatoid arthritis?. Arthritis Rheum 2010, 62:1842-1848.
21. Nelson J.L., Hughes K.A., Smith A.G., et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993, 329:466-471.
22. Brennan P. HLA sharing and history of miscarriage among women with rheumatoid arthritis. Am J Hum Genet 1997, 60:738-739.
23. Gonzalez D.A., de Leon A.C., Moncholi C.V., Cordova Jde C., Hernandez L.B. Arthritis in mice: allogeneic pregnancy protects more than syngeneic by attenuating cellular immune response. J Rheumatol 2004, 31:30-34.
24. Chaouat G., Tranchot Diallo J., Volumenie J.L., Menu E., Gras G., Delage G., et al. Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personal tribute to Tom Wegmann. Am J Reprod Immunol 1997, 37:427-434.
25. Van der Horst-Bruinsma I.E., de Vries R.R.P., de Buck P.D.M., et al. Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Ann Rheum Dis 1998, 57:286-290.
26. Brennan P., Barrett J., Fiddler M., Thomson W., Payton T., Silman A. Maternal-fetal HLA incompatibility and the course of inflammatory arthritis during pregnancy. J Rheumatol 2000, 27:2843-2848.
27. Yan Z., Lambert N.C., Østensen M., Adams K.M., Guthrie K.A., Nelson J.L. Prospective study of fetal DNA in serum and Disease Activity During Pregnancy in Women with inflammatory Arthritis. Arthritis Rheum 2006, 54:2069-2073.
28. Østensen M., Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 1983, 26:1155-1159.
29. Barrett J.H., Brennan P., Fiddler M., et al. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999, 42:1219-1227.
30. de Man Y.A., Dolhain R.J., van de Geijn F.E., Willemsen S.P., Hazes J.M. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008, 59:1241-1248.
31. de Man Y.A., Bakker L.E., van den Goorbergh D.D., Tillemans S.P.R., Hooijkaas H., Hazes J.M.W., et al. Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy. Ann Rheum Dis 2009, 10.1136/ard.2008.104331.
32. Gran J.T., Østensen M. Spondyloarthritides in females. Bailliére's Clin Rheumatol 1998, 12:695-715.
33. Østensen M., Husby G., Romberg Ø. Ankylosing spondylitis and motherhood. Arthritis Rheum 1982, 25:140-143.
34. Østensen M., Østensen H. Ankylosing spondylitis - the female aspect. J Rheumatol 1998, 25:120-124.
35. Mintz G., Niz J., Gutierrez G., et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986, 13:732-739.
36. Lockshin M.D., Reinitz E., Druzin M.L., et al. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984, 77:893-898.
37. Petri M., Howard D., Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991, 34:1538-1545.
38. Wong K.L., Chan F.Y., Lee C.P. Outcome of pregancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991, 151:269-273.
39. Tincani A., Faden D., Tarantini M., Lojacono A., Tanzi P., Gastaldi A., et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992, 10:439-446.
40. Ruiz-Irastorza G., Lima F., Alves J., et al. Increased rate of lupus flare during pregnancy and the puerperium. Br J Rheumatol 1996, 35:133-135.
41. Urowitz M.B., Gladman D.D., Farewell V.T., et al. Lupus and pregnancy studies. Arthritis Rheum 1993, 36:1392-1397.
42. Cortes-Hernandez J., Ordi-Ros J., Paredes F., Casellas M., Castillo F., Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002, 41:643-650.
43. Clowse M.E.B., Magder L.S., Witter F., Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005, 52(2):514-521.
44. Doria A., Ghiradello A., Iaccarino L., et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004, 51:989-995.
45. Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin North Am 2007, 33(2):227-v.
46. Khamashta M.A., Ruiz-Irastorza G., Hughes G.R.V. Systemic lupus erythematosus flares during pregnancy. Rheum Dis Clin North Am 1997, 23:15-30.
47. Janele D., Lang T., Capellino S., Cutolo M., Da Silva J.A., Straub R.H. Effects of testosterone, 17beta-estradiol, and downstream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol. Ann N Y Acad Sci 2006, 1069:168-182.
48. Østensen M., Förger F., Villiger P.M. Cytokines and pregnancy in rheumatic disease. Ann NY Acad Sci 2006, 1069:353-363.
49. Ng S.C., Gilman-Sachs A., Thaker P., Beaman K.D., Beer A.E., Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002, 48(2):77-86.
50. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998, 187:875-883.
51. Ruth J.H., Rottman J.B., Katschke K.J., Qin S., Wu L., LaRosa G., et al. Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 2001, 44:2750-2760.
52. Chaouat G., Ledée-Bataille N., Dubanchet S., Zourbas S., Sandra O., Martal J. Th1/Th2 paradigm in pregnancy: Paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004, 139:93-119.
53. Ashkar A.A., Di Santo J.P., Croy B.A. Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000, 17(192):259-270.
54. Fukushima K., Miyamoto S., Tsukimori K., et al. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 2005, 73:172-179.
55. Lin H., Mosmann T.R., Guilbert L., Tuntipopiat S., Wegmann T.G. Synthesis of T Helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562-4572.
56. Bennett W.A., Lagoo-Deenadaylan S., Whitworth N.S., et al. First trimester human chorionic villi express both immunoregulatory and inflammatory cytokines: A role for interleukin 10 in regulating the cytokine network of pregnancy. Am J Reprod Immunol 1999, 41:70-78.
57. Cadet P., Rady P.L., Trying S.K., Yandell R.B., Hughes T.K. Interleukin messenger ribonucleic acid in human placenta: Implications of a role for interleukin-10 in fetal allograft protection. Am J Obstet Gynecol 1995, 173:25-29.
58. Crome S.Q., Wang A.Y., Levings M.K. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol 2010, 159(2):109-119.
59. Betteli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007, 8(4):345-350.
60. Nyirenda M.H., Sanvito L., Darlington P.J., et al. TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function. J Immunol 2011, 187(5):2278-2290.
61. Pernis A.B. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med 2009, 265(6):644-652.
62. Bowness P., Ridley A., Shaw J., Chan A.T., Wong-Baeza I., Fleming M., et al. Th17 cells expressing Kir3DL2+ and responsive to HLA B27-homodimers are increased in ankylosing spondylitis. J Immunol 2011, 186(4):2672-2680.
63. Toldi G., Rigó J., Stenczer B., Vásárhelyi B., Molvarec A. Increased prevalence of IL-17 producing peripheral blood lymphocytes in pre-eclampsia. Am J Reprod Immunol 2011, 66(3):223-229.
64. Saini V., Arora S., Yadav A., Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clin Chim Acta 2011, 412(9-10):702-708.
65. Opsjon S.L., Wathen N.C., Tingulstad S., Wiedswang G., Sundan A., Waage A., et al. Tumor necrosis factor, interleukin 1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993, 169:397-404.
66. Hebisch G., Neumaier-Wagner P.M., Huch R., von Mandach U. Maternal serum interleukin-1 beta, -6 & -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med 2004, 32:475-480.
67. Makhseed M., Raghupathy R., Azizieh F., Farhat R., Hassan N., Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod 2000, 15:2011-2017.
68. Russwurm G.P., Mackler A.M., Fagoaga O.R., Brown W.S., Sakala E.P., et al. Soluble human leukocyte antigens, interleukin-6, and interferon-gamma during pregnancy. Am J Reprod Immunol 1997, 38:256-262.
69. Fasouliotis S.J., Spandorfer S.D., Wittkin S.S., et al. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Hum Reprod 2004, 19:1357-1363.
70. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., Socol M.L. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996, 88:420-427.
71. Bahar A.M., Ghalib H.W., Moosa R.A., Zaki M.S.Z., Thomas C., Nabri O.A. Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-α and interferon-γ in preterm labor. Acta Obstet Gynecol Scand 2003, 82:543-549.
72. Austgulen R., Lien E., Liabakk N.B., Jacobsen G., Arntzen K.J. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1994, 57:149-155.
73. Kupferminc M.J., Peaceman A.M., Aderka D., Wallach D., Peyser R.M., Lessing J.B., et al. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 1995, 173:900-905.
74. Denney J.M., Nelson E.L., Wadhwa P.D., Waters T.P., Mathew L., Chung E.K., et al. Longitudinal modulation of immune system cytokine profile during pregnancy. Cytokine 2011, 53:170-177.
75. Elenkov I.J., Wilder R.L., Bakalov V.K., Link A.A., Dimitrov M.A., Fisher S., et al. L-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001, 86:4933-4938.
76. Ekerfelt C., Matthiesen L., Berg G. Ernerudh J Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: demonstrated by a novel one-way MLC measuring cytokine secretion. Am J Reprod Immunol 1997, 38(5):320-326.
77. Ekerfelt C., Matthiesen L., Berg G., Ernerudh J. Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy. Am J Reprod Immunol 1998, 39:362-367.
78. Tranchot-Diallo J., Gras G., Parnet-Mathieu F., et al. Modulations of cytokine expression in pregnant women. Am J Reprod Immunol 1997, 37:215-226.
79. Lashley L.E., van der Hoorn M.L., van der Mast B.J., Tilburgs T., van der Lee N., van der Keur C., et al. Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus. Hum Immunol 2011, 72:805-811.
80. Szekeres-Bartho J., Faust Z., Varga P. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 1995, 34:342-348.
81. Szereday L., Varga P., Szekeres-Bartho J. Cytokine production by lymphocytes in pregnancy. Am J Reprod Immunol 1997, 38:418-422.
82. Piccini M.P., Giudizi M.G., Biagiotti R., et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995, 155:128-133.
83. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998, 161:3365-3374.
84. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003, 3:253-257.
85. Morgan M.E., Flierman R., van Duivenvoorde L.M., et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005, 52:2212-2221.
86. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
87. brightCD4+ T cells in rheumatic joints. Scand J Immunol 2006, 63:444-452.
88. high regulatory T cell population in peripheral blood. Rheumatology 2006, 45:1210-1217.
89. brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003, 33:215-223.
90. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004, 172:6435-6443.
91. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004, 200:277-285.
92. Valencia X., Stephens G., Goldbach-Mansky R., Wilson M., Shevach E.M., Lipsky P.E. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108:253-261.
93. Flores-Borja F., Jury E.C., Mauri C., Ehrenstein M.R. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci U S A 2008, 105:19396-19401.
94. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 3:266-271.
95. Sasaki Y., Miyazaki S., Sakai M., Saito S. CD4+CD25+ regulatory T cells are increased in the human early pregnancy deciduas and have immunosuppressive activity. Am J Reprod Immunol 2003, 49:356.
96. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD4+CD25+ regulatory T cell subset. Immunology 2004, 112:38-43.
97. Saito S., Shiozaki A., Sasaki Y., Nakashima A., Shima T., Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol 2007, 29:115-122.
98. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol 2005, 170:85-92.
99. Tilburgs T., Scherjon S.A., van der Mast B.J., Haasnoot G.W., Versteeg V.D.V.-M.M., Roelen D.L., et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009, 82:148-157.
100. Ochanuna Z., Geiger-Maor A., Dembinsky-Vaknin A., Karussis D., Tykocinski M.L., Rachmilewitz J. Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14. PLoS One 2010, 5:e12868.
101. Prieto G.A., Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4+CD25+ regulatory T cells by promoting their proliferation. Immunology 2006, 118:58-65.
102. Østensen M., Fuhrer L., Mathieu R., Seitz Michael, Villiger Peter M. A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments. Ann Rheum Dis 2004, 63:1212-1217.
103. Wais T., Fierz W., Stoll T., Villiger P.M. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission. J Rheumatol 2003, 30:2133-2139.
104. Tak P.P., Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis. Arthritis Rheum 2000, 43:2619-2633.
105. Keller C., Webb A., Davis J. Cytokines in the seronegative spondylarthropathies and their modification by TNF blockade: a brief report and literature review. Ann Rheum Dis 2003, 62:1128-1132.
106. Østensen M., Förger F., Nelson J.Lee, Schuhmacher Aglaja, Hebisch Gundula, Villiger Peter M. Pregnancy in patients with rheumatic disease: Anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005, 64:839-844.
107. Vannier E., Miller L.C., Dinarello C.A. Coordinated antiinflammatory effects of interleukin-4: inerleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci 1992, 89:4076-4080.
108. Joyce D.A., Steer J.H. IL-4, IL-10 and IFN-y have distinct, but interacing, effects of differentiation-induced changes in TNF-α and receptor release by cultured human monocytes. Cytokine 1996, 8:49-57.
109. Østensen M., Sicher Petra, Förger Frauke, Villiger Peter M. Activation markers of peripheral blood mononuclear cells in late pregnancy and after delivery: a pilot study. Ann Rheum Dis 2005, 64:318-320.
110. Förger F., Marcoli N., Gadola S., Moller B., Villiger P.M., Østensen M. Pregnancy induces numerical and functional changes of CD4+CD25 high regulatory T cells in patients with rheumatoid arthritis. Ann Rheum Dis 2008, 67:984-990.
111. Förger F., Villiger P.M., Østensen M. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role?. Arthritis Rheum 2009, 61:279-283.
112. Häupl T., Østensen M., Grützkau A., Radbruch A., Burmester G.R., Villiger P.M. Reactivation of rheumatoid arthritis after pregnancy: increased phagocyte and recurring lymphocyte gene activity. Arthritis Rheum 2008, 58:2981-2992.
113. Häupl T., Ostensen M., Grutzkau A., Burmester G.R., Villiger P.M. Interaction between rheumatoid arthritis and pregnancy: correlation of molecular data with clinical disease activity measures. Rheumatology (Oxford) 2008, 47(Suppl 3):iii19-iii22.
114. Luppi P., Haluszczak C., Trucco M., Deloia J.A. Normal pregnancy is associated with peripheral leukocyte activation. Am J Reprod Immunol 2002, 47:72-81.
115. Sacks G.P., Studena K., Sargent K., Redman C.W. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998, 179:80-86.
116. Weix J, Förger F, Häupl T, Surbeck D, Ostensen M, Villiger PM. Influence of pregnancy on the adipocytokine and PPAR pathways in peripheral blood mononuclear cells of healthy donors and RA patients. Arthritis Rheum submitted for publication.
117. Neumann E., Frommer K.W., Vasile M., Muller-Ladner U. Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases?. Arthritis Rheum 2011, 63:1159-1169.
118. Doria A., Iaccarino L., Sarzi-Puttini P., Ghirardello A., Zampieri S., Arienti S., et al. Estrogens in pregnancy and systemic lupus erythematosus. Ann N Y Acad Sci 2006, 1069:247-256.
119. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
120. Shapiro-Shelef M., Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005, 5:230-242.
121. Conti P., Kempuraj D., Kandere K., Di Gioacchino M., Barbacane R.C., Castellani M.L., et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003, 86(2):123-129.
122. Munoz-Valle J.F., Vazquez-Del Mercado M., Garcia-Iglesias T., et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol 2003, 131:377-384.
123. Tucci M., Stucci S., Stripoli S., Silvestris F. Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus. J Biomed Biotechnol 2010, 2010:457146.
124. Venigalla R.K., Tretter T., Krienke S., et al. Reduced CD4+, CD25- T Cell Sensitivity to the Suppressive Function of CD4+, CD25 high, CD127 low regulatory T Cells in Patients with Active Systemic Lupus Erythematosus. Arthritis Rheum 2008, 58(7):2120-2130.
125. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178(4):2579-2588.
126. Ma J., Yu J., Tao X., Cai L., Wang J., Zheng S.G. The imbalance between regulatory and IL-17 secreting CD4+ T cells in lupus patients. Clin Rheumatol 2010, 29(11):1251-1258.
127. Tower C., Crocker I., Chirico D., Baker P., Bruce I. SLE and pregnancy: the potential role for regulatory T cells. Nat Rev Rheumatol 2011, 7:124-128.
128. Toldi G., Molvarec A., Stenczer B., Müller V., Eszes N., Bohács A., et al. Peripheral Th1/Th2/Th17/regulatory T-cell balance in asthmatic pregnancy. Int Immunol 2011, 23(11):669-677.
129. Lories R.J., Baeten D.L.P. Differences in pathophysiologiy between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009, 27(Suppl 55):S10-S14.
130. Szalay B., Meszaros G., CseH A., et al. Adaptive Immunity in Ankylosing Spondylitis: Phenotype and Functional Alterations of T-Cells before and during Infliximab Therapy. Clin Dev Immunol 2011, 10.1155/2012/808724.
131. Vandooren B., Nooredenbost T., Ambarus C., Krausz S., Cantaert T., Yeremenko N., et al. Absence of a classical activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009, 60:966-975.
132. Kruithof E., Baeten D., De Rycke L., et al. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005, 7:569-580.
133. Jandus C., Bioley R., Rivalis J.P., Dudler J., Speiser D., Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008, 58:2307-2317.